A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Nebivolol
Lasmiditan may increase the bradycardic activities of Nebivolol.
2,5-Dimethoxyamphetamine
Cyclandelate
Lasmiditan may increase the bradycardic activities of Cyclandelate.
2,5-Dimethoxyamphetamine
Prenylamine
Lasmiditan may increase the bradycardic activities of Prenylamine.
2,5-Dimethoxyamphetamine
Nimesulide
Lasmiditan may increase the bradycardic activities of Nimesulide.
2,5-Dimethoxyamphetamine
WIN 55212-2
WIN 55212-2 may increase the bradycardic activities of Lasmiditan.
2,5-Dimethoxyamphetamine
Otilonium
Lasmiditan may increase the bradycardic activities of Otilonium.
2,5-Dimethoxyamphetamine
Trimebutine
Lasmiditan may increase the bradycardic activities of Trimebutine.
2,5-Dimethoxyamphetamine
Hydroxyamphetamine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Hydroxyamphetamine.
2,5-Dimethoxyamphetamine
Valproate bismuth
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Valproate bismuth.
2,5-Dimethoxyamphetamine
Gepefrine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Gepefrine.
2,5-Dimethoxyamphetamine
Methoxyphenamine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Methoxyphenamine.
2,5-Dimethoxyamphetamine
Nicomorphine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Nicomorphine.
2,5-Dimethoxyamphetamine
Mephedrone
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Mephedrone.
2,5-Dimethoxyamphetamine
Ritobegron
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Ritobegron.
2,5-Dimethoxyamphetamine
Iofetamine I-123
The risk or severity of serotonin syndrome can be increased when Iofetamine I-123 is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Methylthioninium
The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of serotonin syndrome can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Aripiprazole lauroxil
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Aripiprazole lauroxil.
2,5-Dimethoxyamphetamine
5-methoxy-N,N-dimethyltryptamine
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with 5-methoxy-N,N-dimethyltryptamine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3